ES487843A0 - Un procedimiento para la preparacion de derivados de imida- zol. - Google Patents

Un procedimiento para la preparacion de derivados de imida- zol.

Info

Publication number
ES487843A0
ES487843A0 ES487843A ES487843A ES487843A0 ES 487843 A0 ES487843 A0 ES 487843A0 ES 487843 A ES487843 A ES 487843A ES 487843 A ES487843 A ES 487843A ES 487843 A0 ES487843 A0 ES 487843A0
Authority
ES
Spain
Prior art keywords
imida
zol
derivatives
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES487843A
Other languages
English (en)
Other versions
ES8101557A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp
Pfizer Inc
Original Assignee
Pfizer Corp
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp, Pfizer Inc filed Critical Pfizer Corp
Publication of ES8101557A1 publication Critical patent/ES8101557A1/es
Publication of ES487843A0 publication Critical patent/ES487843A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
ES487843A 1979-01-19 1980-01-18 Un procedimiento para la preparacion de derivados de imida- zol. Granted ES487843A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7902114 1979-01-19

Publications (2)

Publication Number Publication Date
ES8101557A1 ES8101557A1 (es) 1980-12-16
ES487843A0 true ES487843A0 (es) 1980-12-16

Family

ID=10502633

Family Applications (1)

Application Number Title Priority Date Filing Date
ES487843A Granted ES487843A0 (es) 1979-01-19 1980-01-18 Un procedimiento para la preparacion de derivados de imida- zol.

Country Status (31)

Country Link
US (2) US4555516A (es)
JP (1) JPS5946504B2 (es)
KR (1) KR840001707B1 (es)
AR (1) AR222204A1 (es)
AT (1) AT373880B (es)
AU (1) AU517241B2 (es)
BE (1) BE881245A (es)
CA (1) CA1137481A (es)
CH (1) CH646154A5 (es)
DD (1) DD148773A5 (es)
DE (1) DE3001762A1 (es)
DK (1) DK531479A (es)
ES (1) ES487843A0 (es)
FI (1) FI800143A (es)
FR (1) FR2446828A1 (es)
GR (1) GR71914B (es)
HU (1) HU184227B (es)
IE (1) IE49364B1 (es)
IL (1) IL59150A (es)
IT (1) IT1140523B (es)
LU (1) LU82087A1 (es)
NL (1) NL8000333A (es)
NO (1) NO800131L (es)
NZ (1) NZ192640A (es)
PH (1) PH14910A (es)
PL (1) PL123985B1 (es)
PT (1) PT70707A (es)
SE (1) SE8000435L (es)
SU (1) SU906374A3 (es)
YU (1) YU11380A (es)
ZA (1) ZA80298B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK157860C (da) * 1979-06-07 1990-07-30 Shionogi & Co Analogifremgangsmaade til fremstilling af benzylimidazolderivater samt farmaceutisk acceptable syreadditionssalte deraf
JPS56113766A (en) * 1980-02-12 1981-09-07 Teijin Ltd Novel 1-substituted imidazole derivative and its preparation
JPS57169452A (en) * 1981-04-14 1982-10-19 Teikoku Hormone Mfg Co Ltd Novel phenoxyalkylamide derivative
DE3235589A1 (de) * 1982-09-25 1984-03-29 Hoechst Ag, 6230 Frankfurt Benzylether von phenol-mannich-basen, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen, zwischenprodukte und verfahren zu deren herstellung
DE3424944A1 (de) * 1984-07-06 1986-02-06 Hoechst Ag, 6230 Frankfurt Neue imidazolyverbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
US4937250A (en) * 1988-03-07 1990-06-26 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
US5210079A (en) * 1988-01-07 1993-05-11 E. I. Du Pont De Nemours And Company Treatment of chronic renal failure with imidazole angiotensin-II receptor antagonists
CA1338238C (en) 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US5354867A (en) * 1988-12-06 1994-10-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
EP0479892A1 (en) * 1989-06-30 1992-04-15 E.I. Du Pont De Nemours And Company Fused-ring aryl substituted imidazoles
US5073566A (en) * 1989-11-30 1991-12-17 Eli Lilly And Company Angiotensin ii antagonist 1,3-imidazoles and use thereas
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
US5332820A (en) * 1991-05-20 1994-07-26 E. I. Du Pont De Nemours And Company Dibenzobicyclo(2.2.2) octane angiotensin II antagonists
US5401851A (en) * 1992-06-03 1995-03-28 Eli Lilly And Company Angiotensin II antagonists
US5612360A (en) * 1992-06-03 1997-03-18 Eli Lilly And Company Angiotensin II antagonists
NO304429B1 (no) * 1992-12-17 1998-12-14 Sankyo Co Bifenylderivater, farmas°ytisk preparat og deres anvendelse for fremstilling av et medikament for behandling av hypertensjon og hjertesykdom
WO1995029163A1 (fr) * 1994-04-27 1995-11-02 Nippon Soda Co., Ltd. Derive d'imidazole et procede de production de ce derive
TW434240B (en) * 1995-06-20 2001-05-16 Zeneca Ltd Aromatic compounds, preparation thereof and pharmaceutical composition comprising same
EP0881218B1 (en) * 1995-12-27 2003-10-22 Mitsubishi Pharma Corporation Preventives/remedies for complications of diabetes
JP4056589B2 (ja) * 1996-07-19 2008-03-05 武田薬品工業株式会社 複素環化合物、その製造法および用途
IT1295405B1 (it) 1997-09-30 1999-05-12 Merck Sharp & Dohme Italia S P Uso di un antagonista recettoriale di angiotensina ii per la preparazione di farmaci per aumentare il tasso di sopravvivenza di
KR100423890B1 (ko) * 2000-10-19 2004-03-24 씨제이 주식회사 세팔로스포린 유도체의 새로운 제조방법
TW200505913A (en) * 2003-03-28 2005-02-16 Hoffmann La Roche Novel oxazole derivatives, their manufacture and use as pharmaceutical agents
CN117624052B (zh) * 2024-01-26 2024-04-12 四川益能康生环保科技有限公司 一种用于捕集二氧化碳的离子液体及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH271776A (de) * 1949-01-06 1950-11-15 Ag J R Geigy Verfahren zur Herstellung eines basischen Äthers eines ortho-substituierten Phenols.
US3498999A (en) * 1966-04-20 1970-03-03 Bristol Myers Co 1-phenoxy and substituted phenoxy-3-(5-tetrazolyl) propanes
IE40911B1 (en) * 1974-04-11 1979-09-12 Schering Ag Imidazole derivatives and process for their manufacture
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
US4085209A (en) * 1975-02-05 1978-04-18 Rohm And Haas Company Preparation and safening effect of 1-substituted imidazole metal salt complexes
DE2646143A1 (de) * 1976-10-13 1978-04-20 Bayer Ag 4,5-dichlor-imidazol-1-carbonsaeure- arylester, verfahren zu ihrer herstellung sowie ihre verwendung als pflanzenschutzmittel
JPS5951943B2 (ja) * 1978-08-21 1984-12-17 キツセイ薬品工業株式会社 新規なイミダゾ−ル誘導体

Also Published As

Publication number Publication date
CA1137481A (en) 1982-12-14
DK531479A (da) 1980-07-20
PH14910A (en) 1982-01-29
ES8101557A1 (es) 1980-12-16
PT70707A (en) 1980-02-01
FR2446828A1 (fr) 1980-08-14
IE49364B1 (en) 1985-09-18
FI800143A (fi) 1980-07-20
IL59150A0 (en) 1980-05-30
US4555516A (en) 1985-11-26
IL59150A (en) 1983-11-30
AT373880B (de) 1984-02-27
IT8019276A0 (it) 1980-01-17
BE881245A (fr) 1980-07-18
ZA80298B (en) 1981-08-26
IT1140523B (it) 1986-10-01
SE8000435L (sv) 1980-07-20
FR2446828B1 (es) 1983-05-13
YU11380A (en) 1983-04-30
CH646154A5 (de) 1984-11-15
IE800102L (en) 1980-07-19
PL221461A1 (es) 1980-09-22
ATA24680A (de) 1983-07-15
GR71914B (es) 1983-08-16
US4448781A (en) 1984-05-15
NL8000333A (nl) 1980-07-22
PL123985B1 (en) 1982-12-31
SU906374A3 (ru) 1982-02-15
AU517241B2 (en) 1981-07-16
KR840001707B1 (ko) 1984-10-16
AU5474380A (en) 1980-07-24
KR830001905A (ko) 1983-05-19
LU82087A1 (fr) 1980-04-23
JPS5946504B2 (ja) 1984-11-13
AR222204A1 (es) 1981-04-30
JPS55100368A (en) 1980-07-31
DE3001762A1 (de) 1980-07-24
HU184227B (en) 1984-07-30
NO800131L (no) 1980-07-21
NZ192640A (en) 1984-07-31
DD148773A5 (de) 1981-06-10

Similar Documents

Publication Publication Date Title
ES497304A0 (es) Un procedimiento para la preparacion de nuevos derivados de diarilamino-fluorano.
ES491534A0 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol.
ES496442A0 (es) Un procedimiento para la preparacion de derivados de 2,4-diaminoquinazolina
ES487843A0 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES486782A0 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES477509A0 (es) Un procedimiento para la preparacion de derivados de fenil- piperacina.
ES488886A0 (es) Un procedimiento para la preparacion de derivados acidos penemcarboxilicos.
ES497640A0 (es) Un procedimiento para la preparacion de derivados de la 7- amino-4-trifluormetilcumarina
ES494131A0 (es) Un procedimiento para la preparacion de diariltiofenos.
ES491944A0 (es) Un procedimiento para la preparacion de tienamicinas.
ES495586A0 (es) Un procedimiento para la preparacion de derivados de oxazo- lidona- o tiazolidona.
ES495163A0 (es) Un procedimiento para la preparacion de derivados de carboestirilo.
ES491835A0 (es) Un procedimiento para la preparacion de mono-y-di-esteres desacarosa.
ES500383A0 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
ES490510A0 (es) Un procedimiento para la preparacion de derivados de penici-lina
ES490722A0 (es) Un procedimiento para la preparacion de nuevos derivados de piridazina.
ES507997A0 (es) Un procedimiento para la preparacion de nuevos derivados de la quinoleina.
ES495589A0 (es) Un procedimiento para la preparacion de derivados de imida- lol.
ES495865A0 (es) Un procedimiento para la preparacion de derivados de quina- zolina
ES494130A0 (es) Un procedimiento para la preparacion de nuevos derivados de benzoxocina.
ES495932A0 (es) Un procedimiento para la preparacion de derivados de piridi-na o de pirimidina.
ES490277A0 (es) Un procedimiento para la preparacion de aminoeteres.
ES490289A0 (es) Un procedimiento para la preparacion de derivados de xantina
ES495519A0 (es) Un metodo para la preparacion de derivados peniciclinicos.
ES500381A0 (es) Un procedimiento para la preparacion de derivados de pirro- lidina